Neimeth International Pharmaceuticals Plc announced earnings results for the third quarter ended June 30, 2021. For the third quarter, the company announced sales was NGN 709.720 million compared to NGN 840.870 million a year ago. Operating income was NGN 127.652 million compared to NGN 266.120 million a year ago. Net income was NGN 56.523 million compared to NGN 181.031 million a year ago. Basic earnings per share from continuing operations was NGN 0.0298 compared to NGN 0.1 a year ago. For the nine months, sales was NGN 1,991.296 million compared to NGN 2,006.036 million a year ago. Operating income was NGN 198.274 million compared to NGN 406.381 million a year ago. Net income was NGN 84.828 million compared to NGN 237.627 million a year ago. Basic earnings per share from continuing operations was NGN 0.0447 compared to NGN 0.12512 a year ago.